The main market opportunities lie in adapting FDA-regulated computer system validation methods to align with GAMP®5 Second Edition and CSA, embracing innovative technologies like AI, ML, and ...

This is a continuation of an earlier article in this issue, where the importance of ‘Data Integrity’ was elaborated. The opinions are generalized to a certain extent, only to drive home the point and ...

Commerce minister Piyush Goyal had recently said that data exclusivity could help attract R&D investments in the pharmaceuticals sector. However, data exclusivity to originator firms could facilitate ...

DUBLIN--(BUSINESS WIRE)--The "Efficient Batch Record Design and Review" training has been added to ResearchAndMarkets.com's offering. This online training is designed for professionals in the ...

The Swedish government is opposed to shortening the regulatory data protection period for new medicines, as currently proposed by the EU Commission in its pharma legislative overhaul. Swedish key ...

Survey finds AI to enhance productivity and cut costs in the next 12 months AI is poised to significantly lower pharmaceutical R&D costs through efficient drug discovery, optimised clinical trials, ...

Jay Richetelli, VP of Client Partnerships at DeepIntent, shares how artificial intelligence (AI) is transforming pharma marketing. He breaks down how generative Al is revolutionizing the creative ...

aTyr Pharma's pivotal data readouts in 2025 for SSc-ILD (Phase 2) and pulmonary sarcoidosis (Phase 3) could significantly impact its market potential and approval prospects. Efzofitimod shows promise ...